CCF Highlights

March 2022, Vol 3, No 1 — March 29, 2022
On the second day of the 2022 Cholangiocarcinoma Foundation annual meeting, Lipika Goyal, MD, MPhil, Assistant Professor of Medicine, Harvard Medical School, and Lead, Liver Cancer Research Program, Massachusetts General Hospital Cancer Center, Boston, presented a clinical update on emerging systemic therapies in cholangiocarcinoma (CCA).
Read More

March 2022, Vol 3, No 1 — March 29, 2022
The International Cholangiocarcinoma Research Network (ICRN) is a program initiated by the Cholangiocarcinoma Foundation (CCF). The core mission of this network of international experts is “to rapidly translate scientific discoveries into practice for cholangiocarcinoma patients through a collaborative, highly translational international research network.”
Read More

October 2020, Vol 1, No 2 — October 29, 2020
At the 2020 virtual conference of the Cholangiocarcinoma Foundation (CCF), William W. Li, MD, Chief Executive Officer, President, and Medical Director of the Angiogenesis Foundation in Cambridge, MA, presented the keynote address titled “Dietary Modification of the Tumor Microenvironment: New Frontiers in Cancer Research and Therapy.”
Read More

October 2020, Vol 1, No 2 — October 29, 2020
At the 2020 virtual conference of the Cholangiocarcinoma Foundation (CCF), results of a patient survey conducted in summer 2019 by the CCF and Incyte Corporation, provided real-life responses from patients regarding the impact of a cholangiocarcinoma (CCA) diagnosis on patients with this rare disease.
Read More

October 2020, Vol 1, No 2 — October 29, 2020
At the 2020 virtual conference of the Cholangiocarcinoma Foundation, a panel of experts focused on the science of cholangiocarcinoma (CCA) addressed the topic of “Genetic Disposition for CCA,” which was moderated by Anna Lleo De Nalda, MD, PhD, Associate Professor, Internal Medicine, Humanitas University, Milan, Italy. The panel members responded to questions from the attendees.
Read More

October 2020, Vol 1, No 2 — October 29, 2020
Cancer is a personal journey. We often see and hear from patients, families, and their caregivers about how this disease changes their lives. However, what is often missing is a physician’s view of the role that the physician plays in the battle against cancer.
Read More

October 2020, Vol 1, No 2 — October 29, 2020
Cholangiocarcinoma (CCA) knows no geographic borders. Nevertheless, some geographical areas in the world are associated with increased risk for this type of cancer, according to recent research. At the 2020 virtual conference of the Cholangiocarcinoma Foundation, several experts presented global perspectives related to global trends in CCA.
Read More

October 2020, Vol 1, No 2 — October 29, 2020
The 2020 virtual conference of the Cholangiocarcinoma Foundation (CCF) was wrapped up with reflections on the meeting highlights and key takeaways from the meeting chairs and organizers.
Read More

August 2020, Vol 1, No 1 — September 10, 2020
Rachna T. Shroff, MD, MS, Chief, Section of GI Medical Oncology, University of Arizona Cancer Center, Tucson, and Co-Chair of the 2020 Cholangiocarcinoma Foundation Annual Conference, provided an update of important global clinical trial developments since the last conference of the foundation. Dr Shroff reminded the audience that the ABC-02 clinical trial established the use of gemcitabine and cisplatin chemotherapy as the standard of care for patients with metastatic or unresectable cholangiocarcinoma (CCA) since 2010.
Read More

August 2020, Vol 1, No 1 — September 10, 2020
During the 2020 Cholangiocarcinoma Foundation (CCF) Annual Conference, Melinda Bachini, Director of Advocacy for the foundation, presented an update on the foundation’s advocacy activities and initiatives toward promotion of the cholangiocarcinoma (CCA) community.
Read More

Page 3 of 4


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: